Abstract:AIM: To detect the effect of acid fibroblast growth factor (aFGF) on P53 and P21WAF-1 expression in rat intestine after ischemia-reperfusion (I-R) injury in order to explore the protective mechanisms of aFGF.METHODS: Male rats were randomly divided into four groups, namely intestinal ischemia-reperfusion group (R), aFGF treatment group (A), intestinal ischemia group (I), and sham-operated control group (C). In group I, the animals were killed after 45 min of superior mesenteric artery (SMA) occlusion. In groups R and A, the rats sustained for 45 min of SMA occlusion and were treated with normal saline (0.15 mL) and aFGF (20 mu g/kg, 0.15 mL), then sustained at various times for up to 48 h after reperfusion. In group C, SMA was separated, but without occlusion. Apoptosis in intestinal villi was determined with terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling technique (TUNEL). Intestinal tissue samples were taken not only for RTPCR to detect P53 and P21WAF-1 gene expression, but also for immunohistochemical analysis to detect P53 and P21WAF-1 protein expression and distribution.RESULTS: In histopathological study, ameliorated intestinal structures were observed at 2, 6, and 12 h after reperfusion in A group compared to R group. The apoptotic rates were (41.17 +/- 3.49)%, (42.83 +/- 5.23)%, and (53.33 +/- 6.92)% at 2, 6, and 12 h after reperfusion, respectively in A group, which were apparently lower than those in R group at their matched time points (50.67 +/- 6.95)%, (54.17 +/- 7.86)%, and (64.33 +/- 6.47)%, respectively, (P < 0.05)). The protein contents of P53 and P21WAF-1 were both significantly decreased in A group compared to R group (P < 0.05) at 2-12 h after reperfusion, while the mRNA levels of P53 and P21WAF-1 in A group were obviously lower than those in R group at 6-12 h after reperfusion (P < 0.05).CONCLUSION: P53 and P21WAF-1 protein accumulations are associated with intestinal barrier injury induced by I-R insult, while intravenous aFGF can alleviate apoptosis of rat intestinal cells by inhibiting P53 and P21WAF-1 protein expression. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

The Intestinal-Liver Axis of FGF15-FGFR4-PPAR Alpha Signal Control Liver Ischemia Reperfusion Injury Through Regulating Autophagy

The Role of Ischemia/Reperfusion Injury in Early Hepatic Allograft Dysfunction

Activation of Farnesoid X Receptor Enhances the Efficacy of Normothermic Machine Perfusion in Ameliorating Liver Ischemia-Reperfusion Injury

The Ileal FGF15/19 to Hepatic FGFR4 Axis Regulates Liver Regeneration after Partial Hepatectomy in Mice

FGF18 alleviates hepatic ischemia-reperfusion injury via the USP16-mediated KEAP1/Nrf2 signaling pathway in male mice

A Role for Intestinal Alkaline Phosphatase in Preventing Liver Fibrosis

Liver X Receptors Activation Attenuates Ischemia Reperfusion Injury of Liver Graft in Rats

KLF6 Alleviates Hepatic Ischemia-Reperfusion Injury by Inhibiting Autophagy

Augmenter of Liver Regeneration Ameliorates Ischemia-Reperfusion Injury in Steatotic Liver Via Inhibition of the TLR4/NF-κB Pathway.

Hepatic interferon regulatory factor 8 expression mediates liver ischemia/reperfusion injury in mice

FGF21 protects against ischaemia reperfusion injury in normal and fatty livers

IRF-1 Promotes Liver Transplant Ischemia/Reperfusion Injury via Hepatocyte IL-15/IL-15Rα Production

FGF4 Protects the Liver from Immune-Mediated Injury by Activating CaMKKβ-PINK1 Signal Pathway to Inhibit Hepatocellular Apoptosis

Fgf15/19-Fgfr4 Signalling Pathway Promote Fatty Liver Regeneration in Mice

VEGF-C attenuates ischemia reperfusion injury of liver graft in rats.

FGF21 modulates immunometabolic homeostasis via the ALOX15/15-HETE axis in early liver graft injury

Exogenous Acid Fibroblast Growth Factor Inhibits Ischemia-Reperfusion-induced Damage in Intestinal Epithelium Via Regulating P53 and P21WAF-1 Expression

FBXW5 aggravates hepatic ischemia/reperfusion injury via promoting phosphorylation of ASK1 in a TRAF6-dependent manner

Lipoxin A4 mitigates ferroptosis via FPR2 signaling during lung ischemia-reperfusion injury

Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling

Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver